| RBRC No. | RBRC02193 |
|||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Type | Transgene Congenic |
 |
||||||||||||||||||||||||
| Species | Mus musculus | |||||||||||||||||||||||||
| Strain name | B6.Cg-Tg(hCD2-CA-AhR/GFP)A | |||||||||||||||||||||||||
| Former Common name | T-cell-specific CA-AhR Tg, Line A | |||||||||||||||||||||||||
| H-2 Haplotype | No Data | |||||||||||||||||||||||||
| Background strain | C57BL/6JJcl | |||||||||||||||||||||||||
| Appearance | ||||||||||||||||||||||||||
| 1 | Appearance | No Data | ||||||||||||||||||||||||
| Genotype | No Data | |||||||||||||||||||||||||
| Strain description | No Data | |||||||||||||||||||||||||
| Health Report |
BRC facility Health Report in the last year and a half
|
|||||||||||||||||||||||||
| Gene Details | ||||||||||||||||||||||||||
| Promoter | human CD2 promoter | |||||||||||||||||||||||||
| 1 | Symbol | CA-AhR | ||||||||||||||||||||||||
| Symbol name | constitutively active aryl-hydrocarbon receptor (AhR) | |||||||||||||||||||||||||
| Chromosome | UN | |||||||||||||||||||||||||
| Common name | No Data | |||||||||||||||||||||||||
| Symbol description | No Data | |||||||||||||||||||||||||
| 2 | Symbol | GFP | ||||||||||||||||||||||||
| Symbol name | Green Fluorescent Protein (Jellyfish) | |||||||||||||||||||||||||
| Chromosome | UN | |||||||||||||||||||||||||
| Common name | No Data | |||||||||||||||||||||||||
| Symbol description | No Data | |||||||||||||||||||||||||
| References | Int Immunopharmacol. 2006 Feb;6(2):279-86. Epub 2005 Sep 8. J Immunol. 2005 Mar 1;174(5):2770-7. Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway.
Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway. |
|||||||||||||||||||||||||
| Research applications | Fluorescent Proteins/lacZ System, Immunology and Inflammation Research |
|||||||||||||||||||||||||
| Specific Term and Conditions | The following terms and conditions will be requested by the DEPOSITOR. The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. The RECIPIENT agrees to include the DEPOSITOR as a co-author in any publications resulted by the use of the BIOLOGICAL RESOURCE. The RECIPIENT should contact the DEPOSITOR in the case of application for any patents or commercial use with the results from the use of the BIOLOGICAL RESOURCE. |
|||||||||||||||||||||||||
| Additional information | ||||||||||||||||||||||||||
| 1 | GFP Transfer License (Japanese / English) Please fill in the Schedule A, and submit two signed copies to us together with two signed copies of RIKEN BRC’s MTA. Please also read Schedule B. Lab HP (Japanese) |
|||||||||||||||||||||||||
| Depositor | Nohara, Keiko (National Institute for Environmental Studies)  |
|||||||||||||||||||||||||
| Strain Status / Availability (Expected delivery) |
|
|||||||||||||||||||||||||
